Showing results (2171-2180 of 2,945) with videos related to

Sort By:
Pageof 295
Molecular Pharmacology|April 19, 2011
Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulatorNicola J Smith, Richard J Ward, Leigh A Stoddart, et al.
Archives of Neurology|August 10, 2011
Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer diseaseCarlos Cruchaga, Petra Nowotny, John S K Kauwe, et al.
Journal of Racial and Ethnic Health Disparities|November 6, 2019
Differences in Driving Outcomes Among Cognitively Normal African American and Caucasian Older AdultsGanesh M Babulal, Sarah H Stout, Monique M Williams, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsAudrey A Keleman, Melody Li, Julie K Wisch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersTaylor J Pedersen, Austin A McCullough, Ruijin Lu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumTaylor J Pedersen, Austin A McCullough, Ruijin Lu, et al.
Bone Marrow Transplantation|January 16, 2008
Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantationK J Thomson, K S Peggs, P Smith, et al.
The Annals of Thoracic Surgery|September 24, 2011
Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery diseaseMichael E Halkos, Thomas A Vassiliades, John S Douglas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphomaKarl S Peggs, Irfan Kayani, Noha Edwards, et al.
Surgical Oncology|September 14, 2019
Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for patients at High-Risk of Peritoneal MetastasesMackenzie C Morris, Vikrom K Dhar, Megan A Stevenson, et al.
Pageof 295